肝癌病论坛

首页 » 常识 » 诊断 » 新型白蛋白纳米颗粒可增强二甲双胍的抗胰岛
TUhjnbcbe - 2021/8/12 16:00:00

德孚医药出版社在国际纳米医学期刊发表了最新文章新型白蛋白纳米颗粒可增强二甲双胍的抗胰岛素抗性-肝癌活性,其内容摘要如下:

Introduction:

Metforminisanidealcandidatetotreatthelivertumorwithinsulinresistancebecauseofitsgoodperformanceinthetreatmentoftype2diabetesandtheadvantageincancertherapy.Weaimtodevelopadeliverysystemwithhigherefficiencythanfreedrug.

Methods:

Metformin-bovineserumalbumin(met-BSA)nanoparticles(NPs)werepreparedusingtheanti-solventprecipitationmethodwithastabilizerofBSAforparticlegrowth.Thetherapeuticeffectofthedrugwastestedbytheinsulin-resistantHepG2cellsandC57BL/6Jmiceataglucosestarvationcondition.TheinteractionmechanismofthedrugandtheproteinduringtheformationoftheNPswastestedusingaseriesofspectroscopy.

Results:

MetforminandBSAformednonporousandsphericalparticlesofaboutnmwithproperlognormaldistributionandthermostability.Thecellularuptake,aswellastheanti-livercanceractivitiesofmet-BSA,wasenhanceddramatically

1
查看完整版本: 新型白蛋白纳米颗粒可增强二甲双胍的抗胰岛